Insider Trading & Ownership of Hanmi Pharmaceutical Co., Ltd.

Location: Seoul, Korea, Republic of
Summary: The estimated value of insider holdings of Hanmi Pharmaceutical Co., Ltd. is at least $101,742 dollars as of 20 Mar 2025. Hanmi Pharmaceutical Co., Ltd. is the 10%+ Owner of Aptose Biosciences Inc. and owns shares of Aptose Biosciences Inc. (APTOF) stock worth about $101.7K.
Signature: HANMI PHARMACEUTICAL CO., LTD.; By: /s/ Haegon Shin, Managing Director, Global Business Division
All Insider Reports: All Insider Reports

Notify me when Hanmi Pharmaceutical Co., Ltd. files a new Insider Trading report.

Ownership of Hanmi Pharmaceutical Co., Ltd.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
APTOF	Aptose Biosciences Inc.	10%+ Owner	$101,742			18 Mar 2025